{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:45:31Z","timestamp":1740141931713,"version":"3.37.3"},"reference-count":29,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100010041","name":"Science and Technology Program of Tianjin","doi-asserted-by":"publisher","award":["13ZCZDSY01400"],"award-info":[{"award-number":["13ZCZDSY01400"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>ST-Segment Elevation Myocardial Infarction (STEMI) patients with the multivessel\ndisease have distinctive plaque characteristics in non-IRA lesions. Intensive statin therapy was\na potential approach to treat STEMI patients with the non-IRA disease. However, there is still poor evidence\nabout the therapeutic effect. In this study, we have evaluated the detailed therapeutic effect of\nstatin plus ezetimibe intensive therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>For STEMI patients with non-IRA disease undergoing primary Percutaneous Coronary Intervention\n(PCI), 183 control STEMI patients without non-IRA disease undergoing primary PCI, and\n200 STEMI patients with non-IRA disease undergoing primary PCI were introduced into this study.\n200 STEMI patients with non-IRA disease undergoing primary PCI were divided into Normal group,\nIntensive group, Normal &amp; Combined group, and Intensive &amp; Combined group. The baseline information\nfor each participant was recorded. Meanwhile, the physiological and biochemical indicators of\neach member with different treatments were collected after one-year follow-up.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>For STEMI patients with non-IRA disease undergoing primary PCI, no differences could be\ndetected in multiple indexes such as OCT examination results, age, stroke, etc. However, diabetes\nmellitus, smoking, and coronary Gensini score were different between different groups (P&lt;0.05). After\none year follow-up, cholesterol, low-density lipoprotein, coronary Gensini score, thin-cap fibroatheroma,\nlength of non-infarcted arterial lesions, non-infarct artery lesion range, myocardial infarction\nagain, and revascularization again were significantly different between different groups (P&lt;0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results mentioned above suggested that pitavastatin combined with ezetimibe was an\neffective approach for STEMI patients with non-IRA disease undergoing primary PCI. The results obtained\nin this study have provided a novel method for the treatment of STEMI patients with non-IRA\ndisease undergoing primary PCI.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201021666200629153421","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T17:03:25Z","timestamp":1593450205000},"page":"549-556","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pitavastatin Combined with Ezetimibe Treatment was an Effective Approach to Non-IRA Lesion of ST-segment Elevation Myocardial Infarction Patients with Primary Percutaneous Coronary Intervention"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-5437","authenticated-orcid":true,"given":"Bo","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-2873","authenticated-orcid":true,"given":"Guang-Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-4907","authenticated-orcid":true,"given":"Jian-Jun","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8841-427X","authenticated-orcid":true,"given":"Li-Hui","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5535-3776","authenticated-orcid":true,"given":"Li-Cheng","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-1095","authenticated-orcid":true,"given":"Hui-Ming","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6481-6522","authenticated-orcid":true,"given":"Zuo-Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-8863","authenticated-orcid":true,"given":"Sheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038,China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcha.2016.01.003","volume":"10","author":"Slavich M.","year":"2016","unstructured":"Slavich M.; Patel R.S.; Coronary artery spasm: Current knowledge and residual uncertainties. Int J Cardiol Heart Vasc 2016,10,47-53","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1136\/hrt.2007.132423","volume":"94","author":"Zhang X.H.","year":"2008","unstructured":"Zhang X.H.; Lu Z.L.; Liu L.; Coronary heart disease in China. Heart 2008,94(9),1126-1131","journal-title":"Heart"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pop.2012.11.003","volume":"40","author":"Nelson R.H.","year":"2013","unstructured":"Nelson R.H.; Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care 2013,40(1),195-211","journal-title":"Prim Care"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"Ference B.A.","year":"2017","unstructured":"Ference B.A.; Ginsberg H.N.; Graham I.; Ray K.K.; Packard C.J.; Bruckert E.; Hegele R.A.; Krauss R.M.; Raal F.J.; Schunkert H.; Watts G.F.; Bor\u00e9n J.; Fazio S.; Horton J.D.; Masana L.; Nicholls S.J.; Nordestgaard B.G.; van de Sluis B.; Taskinen M.R.; Tokg\u00f6zoglu L.; Landmesser U.; Laufs U.; Wiklund O.; Stock J.K.; Chapman M.J.; Catapano A.L.; Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017,38(32),2459-2472","journal-title":"Eur Heart J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s11886-015-0632-6","volume":"17","author":"Banning A.S.","year":"2015","unstructured":"Banning A.S.; Gershlick A.H.; Management of multivessel coronary cisease in sT-segment elevation myocardial infarction. Curr Cardiol Rep 2015,17(9),632","journal-title":"Curr Cardiol Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1161\/01.CIR.0000072768.80031.74","volume":"107","author":"Kotani J.","year":"2003","unstructured":"Kotani J.; Mintz G.S.; Castagna M.T.; Pinnow E.; Berzingi C.O.; Bui A.B.; Pichard A.D.; Satler L.F.; Suddath W.O.; Waksman R.; Laird J.R.; Kent K.M.; Weissman N.J.; Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003,107(23),2889-2893","journal-title":"Circulation"},{"key":"ref=7","first-page":"e77","volume":"18","author":"Sahin D.Y.","year":"2013","unstructured":"Sahin D.Y.; G\u00fcr M.; Elbasan Z.; Y\u0131ld\u0131z A.; Kaya Z.; I\u00e7en Y.K.; K\u0131vrak A.; T\u00fcrko\u011flu C.; Y\u0131lmaz R.; Cayl\u0131 M.; Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: Importance of neutrophil to lymphocyte ratio and uric acid level. Exp Clin Cardiol 2013,18(2),e77-e81","journal-title":"Exp Clin Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"Libby P.","year":"2013","unstructured":"Libby P.; Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013,368(21),2004-2013","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/eurheartj\/eht308.P1274","volume":"34","author":"Elbasan Z.","year":"2013","unstructured":"Elbasan Z.; Gur M.; Sahin D.Y.; The effect of chronic statin use on patency of infarct related artery in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J 2013,34(Suppl. 1),1274","journal-title":"Eur Heart J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1248\/bpb.29.634","volume":"29","author":"Wang J.","year":"2006","unstructured":"Wang J.; Tokoro T.; Higa S.; Kitajima I.; Anti-inflammatory effect of pitavastatin on NF-kappaB activated by TNF-\u03b1 in hepatocellular carcinoma cells. Biol Pharm Bull 2006,29(4),634-639","journal-title":"Biol Pharm Bull"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.clinthera.2005.07.007","volume":"27","author":"Park S.","year":"2005","unstructured":"Park S.; Kang H.J.; Rim S.J.; Ha J.W.; Oh B.H.; Chung N.; Cho S.Y.; A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia. Clin Ther 2005,27(7),1074-1082","journal-title":"Clin Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/CE.S8008","volume":"5","author":"Alagona P.","year":"2010","unstructured":"Alagona P.; Jr Pitavastatin: evidence for its place in treatment of hypercholesterolemia. Core Evid 2010,5,91-105","journal-title":"Core Evid"},{"journal-title":"Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia Europ Heart J, 2003, 12(4), 36-37","author":"Knopp R.H","key":"ref=13","unstructured":"Knopp R.H; Gitter H; Truit T;  Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia Europ Heart J, 2003, 12(4), 36-37"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ahj.2014.05.004","volume":"168","author":"Blazing M.A.","year":"2014","unstructured":"Blazing M.A.; Giugliano R.P.; Cannon C.P.; Musliner T.A.; Tershakovec A.M.; White J.A.; Reist C.; McCagg A.; Braunwald E.; Califf R.M.; Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. Am Heart J 2014,168(2),205-12.e1","journal-title":"Am Heart J"},{"key":"ref=15","unstructured":""},{"author":"Zhang H.P.","key":"ref=16","doi-asserted-by":"publisher","unstructured":"Zhang H.P.; Zhao Y.; Li H.; Tang G.D.; Ai H.; Zheng N.X.; Liu J.H.; Sun F.C.;  Impact of chronic total occlusion in a noninfarct- related artery on clinical outcomes in patients with acute STelevation myocardial infarction undergoing primary percutaneous coronary intervention. Medicine (Baltimore), 2016, 95(2), e2441.","DOI":"10.1097\/MD.0000000000002441"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1253\/circj.CJ-11-0365","volume":"75","author":"Ikenaga H.","year":"2011","unstructured":"Ikenaga H.; Ishihara M.; Inoue I.; Kawagoe T.; Shimatani Y.; Miura F.; Nakama Y.; Dai K.; Otani T.; Ejiri K.; Oda N.; Nakamura M.; Miki T.; Usefulness of Lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction. Circ J 2011,75(12),2847-2852","journal-title":"Circ J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1476-511X-13-59","volume":"13","author":"Nozue T.","year":"2014","unstructured":"Nozue T.; Yamamoto S.; Tohyama S.; Fukui K.; Umezawa S.; Onishi Y.; Kunishima T.; Sato A.; Nozato T.; Miyake S.; Takeyama Y.; Morino Y.; Yamauchi T.; Muramatsu T.; Hibi K.; Terashima M.; Michishita I.; Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris. Lipids Health Dis 2014,13(1),59","journal-title":"Lipids Health Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.jacc.2015.09.099","volume":"66","author":"McCann G.P.","year":"2015","unstructured":"McCann G.P.; Khan J.N.; Greenwood J.P.; Nazir S.; Dalby M.; Curzen N.; Hetherington S.; Kelly D.J.; Blackman D.J.; Ring A.; Peebles C.; Wong J.; Sasikaran T.; Flather M.; Swanton H.; Gershlick A.H.; Complete versus lesion-only primary PCI: The\nrandomized cardiovascular MR CvLPRIT substudy. J Am Coll Cardiol 2015,66(24),2713-2724","journal-title":"J Am Coll Cardiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","volume":"373","author":"Sedlis S.P.","year":"2015","unstructured":"Sedlis S.P.; Hartigan P.M.; Teo K.K.; Maron D.J.; Spertus J.A.; Mancini G.B.; Kostuk W.; Chaitman B.R.; Berman D.; Lorin J.D.; Dada M.; Weintraub W.S.; Boden W.E.; Effect of PCI on long-term survival in patients with\nstable ischemic heart disease. N Engl J Med COURAGE Trial Investigators2015,373(20),1937-1946","journal-title":"N Engl J Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1161\/CIRCULATIONAHA.112.092973","volume":"126","author":"Brooks M.M.","year":"2012","unstructured":"Brooks M.M.; Chaitman B.R.; Nesto R.W.; Clinical and angiographic risk stratification and differential impact on treatment outcomes in the bARI 2D trial. Circulation 2012,126(17),2115-2124","journal-title":"Circulation"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/eurheartj\/ehq410","volume":"32","author":"Widimsky P.","year":"2011","unstructured":"Widimsky P.; Holmes D.R.; Jr How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 2011,32(4),396-403","journal-title":"Eur Heart J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","volume":"49","author":"Nico H.J.P.","year":"2007","unstructured":"Nico H.J.P.; Pepijn van S, Ganesh M. Percutaneous coronary intervention of functionally nonsignificant stenosis. J Am Coll Cardiol 2007,49,2105-2111","journal-title":"J Am Coll Cardiol"},{"key":"ref=24","author":"Ikenaga H.","year":"2010","unstructured":"Ikenaga H.; Ishihara M.; Inoue I.; Statin reduces cardiac events after acute myocardial infarction in patients with high lipoprotein (a). Circulation 2010(21)","journal-title":"Circulation"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","volume":"36","author":"R\u00e4ber L.","year":"2015","unstructured":"R\u00e4ber L.; Taniwaki M.; Zaugg S.; Kelb\u00e6k H.; Roffi M.; Holmvang L.; Noble S.; Pedrazzini G.; Moschovitis A.; L\u00fcscher T.F.; Matter C.M.; Serruys P.W.; J\u00fcni P.; Garcia-Garcia H.M.; Windecker S.; IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416). Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur Heart J 2015,36(8),490-500","journal-title":"Eur Heart J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cmet.2008.04.001","volume":"7","author":"Ge L.","year":"2008","unstructured":"Ge L.; Wang J.; Qi W.; Miao H.H.; Cao J.; Qu Y.X.; Li B.L.; Song B.L.; The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab 2008,7(6),508-519","journal-title":"Cell Metab"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212534","author":"Vavlukis M.","year":"2018","unstructured":"Vavlukis M.; Vavlukis A.; Adding ezetimibe to statin therapy: latest evidence and clinical implications. Drugs Context 2018","journal-title":"Drugs Context"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/2040622310389227","volume":"2","author":"Ose L.","year":"2011","unstructured":"Ose L.; Pitavastatin: finding its place in therapy. Ther Adv Chronic Dis 2011,2(2),101-117","journal-title":"Ther Adv Chronic Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.amjcard.2019.01.034","volume":"123","author":"Sharma A.","year":"2019","unstructured":"Sharma A.; Sun J-L.; Lokhnygina Y.; Roe M.T.; Ahmad T.; Desai N.R.; Blazing M.A.; Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT). Am J Cardiol 2019,123(8),1193-1201","journal-title":"Am J Cardiol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201021666200629153421","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183281\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201021666200629153421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T11:02:34Z","timestamp":1655809354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183281\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201021666200629153421","relation":{},"ISSN":["1389-2010"],"issn-type":[{"type":"print","value":"1389-2010"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}